Anti-INGR2/ IFNGR2/ AF-1 monoclonal antibody

Anti-INGR2/ IFNGR2/ AF-1 antibody for FACS & in-vivo assay

Target products collectionGo to IFNGR2/IFNGR2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T30284-Ab-1/ GM-Tg-hg-T30284-Ab-2Anti-Human IFNGR2 monoclonal antibodyHuman
GM-Tg-rg-T30284-Ab-1/ GM-Tg-rg-T30284-Ab-2Anti-Rat IFNGR2 monoclonal antibodyRat
GM-Tg-mg-T30284-Ab-1/ GM-Tg-mg-T30284-Ab-2Anti-Mouse IFNGR2 monoclonal antibodyMouse
GM-Tg-cynog-T30284-Ab-1/ GM-Tg-cynog-T30284-Ab-2Anti-Cynomolgus/ Rhesus macaque IFNGR2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T30284-Ab-1/ GM-Tg-felg-T30284-Ab-2Anti-Feline IFNGR2 monoclonal antibodyFeline
GM-Tg-cang-T30284-Ab-1/ GM-Tg-cang-T30284-Ab-2Anti-Canine IFNGR2 monoclonal antibodyCanine
GM-Tg-bovg-T30284-Ab-1/ GM-Tg-bovg-T30284-Ab-2Anti-Bovine IFNGR2 monoclonal antibodyBovine
GM-Tg-equg-T30284-Ab-1/ GM-Tg-equg-T30284-Ab-2Anti-Equine IFNGR2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T30284-Ab-1/ GM-Tg-hg-T30284-Ab-2; GM-Tg-rg-T30284-Ab-1/ GM-Tg-rg-T30284-Ab-2;
GM-Tg-mg-T30284-Ab-1/ GM-Tg-mg-T30284-Ab-2; GM-Tg-cynog-T30284-Ab-1/ GM-Tg-cynog-T30284-Ab-2;
GM-Tg-felg-T30284-Ab-1/ GM-Tg-felg-T30284-Ab-2; GM-Tg-cang-T30284-Ab-1/ GM-Tg-cang-T30284-Ab-2;
GM-Tg-bovg-T30284-Ab-1/ GM-Tg-bovg-T30284-Ab-2; GM-Tg-equg-T30284-Ab-1/ GM-Tg-equg-T30284-Ab-2
Products NameAnti-IFNGR2 monoclonal antibody
Formatmab
Target NameIFNGR2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IFNGR2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species INGR2/ IFNGR2/ AF-1 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T30284-Ag-1interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2) protein
    ORF Viral VectorpGMLPm000646mouse Ifngr2 Lentivirus plasmid
    ORF Viral VectorvGMLPm000646mouse Ifngr2 Lentivirus particle


    Target information

    Target IDGM-T30284
    Target NameIFNGR2
    Gene ID3460,15980,360697,699489,487739,101092286,514889,100063333
    Gene Symbol and SynonymsAF-1,IFGR2,Ifgt,IFNGR2,IFNGT1,IMD28
    Uniprot AccessionP38484
    Uniprot Entry NameINGR2_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000159128
    Target ClassificationCheckpoint-Immuno Oncology

    The target: IFNGR2, gene name: IFNGR2, also named as AF-1, IFGR2, IFNGT1, IMD28. This gene (IFNGR2) encodes the non-ligand-binding beta chain of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. Defects in IFNGR2 are a cause of mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical mycobacterial infection. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.